Hutchmed (China)
HCM
Ermenegildo Zegna NV
ZGN
New Fortress Energy
NFE
Enerpac Tool
EPAC
eBay
EBAY
US Stock MarketDetailed Quotes
JANX Janux Therapeutics
- 40.720
- +0.110+0.27%
Close Jan 17 16:00 ET
- 40.720
- 0.0000.00%
Post 20:01 ET
2.39BMarket Cap-34.80P/E (TTM)
42.380High40.510Low802.31KVolume41.090Open40.610Pre Close33.09MTurnover1.81%Turnover RatioLossP/E (Static)58.63MShares71.71052wk High3.64P/B1.80BFloat Cap7.79052wk Low--Dividend TTM44.22MShs Float71.710Historical High--Div YieldTTM4.61%Amplitude5.650Historical Low41.243Avg Price1Lot Size
About Janux Therapeutics Company
Janux Therapeutics, Inc. operates preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in La Jolla, CA.
Company Profile
SymbolJANX
Company NameJanux Therapeutics
Listing DateJun 11, 2021
Issue Price17.00
Founded2017
CEODr. David Campbell, PhD
MarketNASDAQ
Employees64
Fiscal Year Ends12-31
Address11099 North Torrey Pines Park,Suite 290
CityLa Jolla
ProvinceCalifornia
CountryUnited States of America
Zip Code92037
Phone1-858-750-4700
Websitehttp://www.januxrx.com
Company Executives
- Name
- Position
- Salary
- Dr. David Campbell, PhD
- Director, President and Chief Executive Officer
- 4.19M
- Dr. Tommy DiRaimondo, PhD
- Chief Scientific Officer
- --
- Tighe Reardon
- Acting Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Byron Robinson, PhD
- Chief Strategy Officer
- 1.74M
- Andy Meyer
- Chief Business Officer
- --
- Charles M. Winter
- Chief Technical Officer
- 1.61M
- Dr. Ronald W. Barrett, PhD
- Chairman of the Board
- 162.69K
- Eric L. Dobmeier
- Director
- --
- Dr. Sheila Gujrathi, M.D.
- Director
- 158.01K
- Natasha A. Hernday
- Director
- --
- Alana B. McNulty
- Independent Director
- 166.57K
- Dr. Jake Sin, PhD
- Independent Director
- 172.07K
- Vickie L. Capps
- Independent Director
- 173.01K
- Winston Kung, M.B.A.
- Independent Director
- 164.77K